Skip to main content
Fig. 2 | Lipids in Health and Disease

Fig. 2

From: Association of apolipoprotein E (APOE) polymorphisms with warfarin maintenance dose in a northern Han Chinese population

Fig. 2

Comparison of daily stable warfarin dose requirements between E2/E3 heterozygotes and E3/E3 homozygotes in two subgroups based on patient INR values. (a) low-intensity anticoagulant treatment group: 1.6 ≤ INR <2.0; (b) relatively high-intensity anticoagulant treatment group: 2.0 ≤ INR ≤2.5, * p < 0.05, analyzed by independent t-tests

Back to article page

Lipids in Health and Disease

ISSN: 1476-511X